Nektar Therapeutics (NKTR) Raw Materials (2010 - 2024)

Nektar Therapeutics' Raw Materials history runs 13 years deep, the most recent figure standing at $1.7 million for Q2 2024.

• In Q2 2024, Raw Materials changed N/A year-over-year to $1.7 million; the TTM figure through Jun 2024 stood at $1.7 million (changed N/A YoY), while the FY2023 annual figure was $1.9 million, down 27.73% from the prior year.
• Raw Materials for Q2 2024 stood at $1.7 million, down from $1.9 million in the prior quarter.
• The five-year high for Raw Materials was $2.6 million in Q4 2022, with the low at $1.7 million in Q2 2024.
• The 3-year median for Raw Materials is $1.9 million (2023), against an average of $2.0 million.
• Peak annual rise in Raw Materials reached 27.73% in 2023, while the deepest fall reached 27.73% in 2023.
• Nektar Therapeutics' Raw Materials stood at $2.6 million in 2022, then decreased by 27.73% to $1.9 million in 2023, then declined by 7.63% to $1.7 million in 2024.
• Business Quant data shows NKTR's Raw Materials at $1.7 million in Q2 2024, $1.9 million in Q1 2024, and $1.9 million in Q4 2023.